AI Verdict
REGN has stronger fundamentals based on our AI analysis.
REGN vs AMZN Fundamental Comparison
| Metric | REGN | AMZN |
|---|---|---|
| Revenue | $3.6B | $181.5B |
| Net Income | $727.2M | $90.8B |
| Net Margin | 20.2% | 50.0% |
| ROE | 2.3% | 20.5% |
| ROA | 1.8% | 9.9% |
| Current Ratio | 3.57x | 1.18x |
| Debt/Equity | 0.06x | 0.28x |
| EPS | $6.75 | $2.78 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
REGN vs AMZN: Frequently Asked Questions
Is REGN or AMZN the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), REGN has stronger fundamentals. REGN is graded A (80% confidence) while AMZN is graded A (74% confidence). This is not investment advice.
How does REGN compare to AMZN fundamentally?
REGENERON PHARMACEUTICALS, INC. has ROE of 2.3% vs AMAZON COM INC's 20.5%. Net margins are 20.2% vs 50.0% respectively.
Which stock pays higher dividends, REGN or AMZN?
REGN has a dividend yield of N/A or no dividend while AMZN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in REGN or AMZN for long term?
For long-term investing, consider that REGN has a A grade with 80% confidence, while AMZN has a A grade with 74% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about REGN vs AMZN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For REGN vs AMZN, the AI consensus favors REGN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.